Romania pharma market in April 2024-March 2025 reached a total value of RON35.2 billion (EUR7.08 billion), 13.4% higher than in the year-earlier period, in line with Cegedim data.
Romanians bought medicines worth RON34 billion (EUR6.86 billion) last year, 13.8% more than in 2023, as prescription drugs in pharmacies totaled RON20.8 billion (up 14.2%) and OTC ones RON8 billion, up 6.2%, in line with a report by consultancy company Cegedim.
Local production of medicines covered 29% of drug sales in Romania in the first six months of 2024, an analysis by market research company Cegedim shows.
Medicine sales went up by 15.5% in the first quarter of 2024 from the year-earlier period, to RON8.15 billion, as retail sales rose by 14.4% and hospital consumption increased by 22.5%, in line with a report by consulting company Cegedim.
Romanians bought medicines worth RON26.8 billion (EUR5.44 billion) in the period April 2022 – March 2023, at wholesale prices, 20% more than in the year-earlier period, in line with a report of consulting company Cegedim.
The value of medicines prescribed to patients in Romania in the October 2022-September 2023 period reached RON28.7 billion (EUR5.8 billion) at wholesale prices, up 16% from the year-earlier period, in line with Cegedim data.
Romanians used medical drugs worth RON19 billion (EUR3.9 billion), at wholesale prices, in the period July 2020-June 2021, 10.6% more than in the year-earlier period, Cegedim research showed Wednesday.